Chronic News and Research

RSS

Microclinic International to promote healthier living in the Cumberland Valley Region

Microclinic International was awarded a major CDC grant to promote healthier living and combat chronic disease in the Cumberland Valley Region in Appalachian Kentucky.

15 May 2013

Southern Denmark to use IBM's Shared Care Platform to improve care for patients with chronic illness

IBM announced today that the Region of Southern Denmark is launching a new program to provide comprehensive insight to improve the quality and comprehensiveness of care for patients with chronic illness.

15 May 2013

New studies support previous findings that reducing dietary sodium intake improves health

Recent studies that examine links between sodium consumption and health outcomes support recommendations to lower sodium intake from the very high levels some Americans consume now, but evidence from these studies does not support reduction in sodium intake to below 2,300 mg per day, says a new report from the Institute of Medicine.

15 May 2013

University of Utah receives $1.9M research award to study asthma in children

The Patient-Centered Outcomes Research Institute has approved a $1.9 million research award to the University of Utah to study asthma in children and how better monitoring of the disease could improve health.

15 May 2013

New report analyzes economic viability of practicing midlevel dental providers in US

A new report assessing the economic viability of services provided by practicing midlevel dental providers in the U.S. shows that they are expanding preventive dental care to people who need it most: children and those who can't afford care.

15 May 2013

LDL cholesterol blood level declines found to have abruptly ended in 2008

Decades of declines in LDL cholesterol blood levels, a key marker of death risk from heart disease, abruptly ended in 2008, and may have stalled since, according to a multi-year, national study published in PLOS ONE.

From Quest Diagnostics 14 May 2013

AbilTo completes Series A financing to expand proprietary programs and technology platform

AbilTo, Inc., a company that delivers proven behavioral health programs to help adults overcome mild and moderate depression associated with major medical events, announced today the completion of a $3 million round of Series A financing to fund the expansion of the Company's proprietary programs and technology platform.

14 May 2013

Experts to give advice and guidance on managing pain among older adults

Older adults living with chronic pain, as well as their families and carers, have the opportunity to give their views to health experts at the University of Greenwich.

14 May 2013

Researchers discover connection between CB1 receptors and PTSD

In a first-of-its-kind effort to illuminate the biochemical impact of trauma, researchers at NYU Langone Medical Center have discovered a connection between the quantity of cannabinoid receptors in the human brain, known as CB1 receptors, and post-traumatic stress disorder, the chronic, disabling condition that can plague trauma victims with flashbacks, nightmares and emotional instability.

14 May 2013

Annual Century for the Cure bike ride supports research on hematologic malignancies

The annual Century for the Cure bike ride that has raised more than $1 million since 2005 for research at The Cancer Institute of New Jersey is now making it possible for new scientific exploration in the area of hematologic malignancies.

14 May 2013

Study suggests that a blood protein contributes to early development of atherosclerosis

It's on Saturday that the Journal of the American Heart Association published the conclusive results from a study directed by Dr. Éric Thorin of the Montreal Heart Institute (MHI), which suggests for the first time that a blood protein contributes to the early development of atherosclerosis.

14 May 2013

Routine depression screening for adults not recommended in primary care settings

For adults with no apparent symptoms of depression, routine screening is not recommended in primary care settings because of the lack of high-quality evidence on the benefits and harms of screening for depression, according to new evidence-based guidelines from the Canadian Task Force on Preventive Health Care published in CMAJ.

14 May 2013

Clinical study reveals that Kava could be an alternative treatment for GAD

A world-first completed clinical study by an Australian team has found Kava, a medicinal South Pacific plant, significantly reduced the symptoms of people suffering anxiety.

14 May 2013

Understanding different forms of hepatitis

It's Hepatitis Awareness Month. Understanding the different forms of hepatitis, who is at risk and how it can be prevented and treated can be confusing.

14 May 2013

NCCC doctors find effective drug combination to treat chronic lymphocytic leukemia

Doctors at Dartmouth-Hitchcock's Norris Cotton Cancer Center have found a combination of drugs to potentially treat chronic lymphocytic leukemia more effectively.

14 May 2013

Researchers identify microRNA-155 as prognostic marker, treatment target in patients with AML

A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope (that is, cytogenetically normal acute myeloid leukemia, or CN-AML).

14 May 2013

Drug cost disparities, small business worries continue to surround health law's implementation

The Associated Press reports on the emergence of concerns regarding the health law and drug cost disparities. Meanwhile, other news outlets report on how employers continue to have angst about the measure's price tag.

14 May 2013

FDA grants priority review for Janssen's simeprevir

Medivir AB today announces that the U.S. Food and Drug Administration has granted Priority Review to the New Drug Application by Janssen for simeprevir (TMC435), an investigational NS3/4A protease inhibitor administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease.

14 May 2013

NAPHS releases new study that examines readmission patterns within Medicare IPF PPS

The National Association of Psychiatric Health Systems today released a new study by The Moran Company that is the first to examine readmission patterns within inpatient psychiatric facilities paid under the Medicare IPF prospective payment system.

13 May 2013

Biogen Idec announces FDA's acceptance of ELOCTATE BLA for treatment of hemophilia A

Biogen Idec announced today that the U.S. Food and Drug Administration has accepted the company's Biologics License Application for the marketing approval of ELOCTATE (recombinant factor VIII Fc fusion protein) for the treatment of hemophilia A.

13 May 2013

Chronic News and Research

Microclinic International to promote healthier living in the Cumberland Valley Region

Southern Denmark to use IBM's Shared Care Platform to improve care for patients with chronic illness

New studies support previous findings that reducing dietary sodium intake improves health

University of Utah receives $1.9M research award to study asthma in children

New report analyzes economic viability of practicing midlevel dental providers in US

LDL cholesterol blood level declines found to have abruptly ended in 2008

AbilTo completes Series A financing to expand proprietary programs and technology platform

Experts to give advice and guidance on managing pain among older adults

Researchers discover connection between CB1 receptors and PTSD

Annual Century for the Cure bike ride supports research on hematologic malignancies

Study suggests that a blood protein contributes to early development of atherosclerosis

Routine depression screening for adults not recommended in primary care settings

Clinical study reveals that Kava could be an alternative treatment for GAD

Understanding different forms of hepatitis

NCCC doctors find effective drug combination to treat chronic lymphocytic leukemia

Researchers identify microRNA-155 as prognostic marker, treatment target in patients with AML

Drug cost disparities, small business worries continue to surround health law's implementation

FDA grants priority review for Janssen's simeprevir

NAPHS releases new study that examines readmission patterns within Medicare IPF PPS

Biogen Idec announces FDA's acceptance of ELOCTATE BLA for treatment of hemophilia A

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News